Protecting Pancreatic ß‐cells

Type 1 diabetes mellitus is an autoimmune disorder in which the insulin‐producing β‐cells of the pancreatic islets of Langerhans are selectively destroyed. Transplantation of allogeneic islets offers a novel therapeutic approach for type 1 diabetic patients. Primary obstacles to the successful outcome of this treatment are loss of the islets occurring first during the isolation procedure and then immediately following transplantation. The genetic make up of β‐cells contributes to making them particularly vulnerable to apoptosis and necrosis‐induced cell death caused by the trauma of the isolation procedure and by non‐specific inflammatory events at the transplantation site. In this review we present description of chemical and molecular biology based strategies to confer cytoprotection to β‐cells. IUBMB Life, 56: 387‐394, 2004

[1]  G. Elgue,et al.  Low-molecular weight dextran sulfate abrogates the instant blood-mediated inflammatory reaction induced by adult porcine islets both in vitro and in vivo. , 2004, Transplantation proceedings.

[2]  Marcela Brissova,et al.  Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. , 2004, Diabetes.

[3]  R. Perfetti,et al.  GLP-1 inhibition of pancreatic islet cell apoptosis , 2004, Trends in Endocrinology & Metabolism.

[4]  A. F. Stewart,et al.  Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. , 2004, Endocrinology.

[5]  J. Bluestone,et al.  Beta-cell replacement for type I diabetes. , 2004, Annual review of medicine.

[6]  M. Park,et al.  Adenoviral mediated hepatocyte growth factor gene attenuates hyperglycemia and β cell destruction in overt diabetic mice , 2003, Experimental & Molecular Medicine.

[7]  D. Harlan,et al.  State of the Art: Islet Transplantation for the Cure of Type 1 Diabetes Mellitus , 2003, Reviews in Endocrine and Metabolic Disorders.

[8]  H. Noushmehr,et al.  Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. , 2003, Endocrinology.

[9]  I. Chaudry,et al.  Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. , 2003, Diabetes.

[10]  C. Berne,et al.  Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation1 , 2003, Transplantation.

[11]  C. McDonald,et al.  Changes in liver enzymes after clinical islet transplantation1 , 2003, Transplantation.

[12]  F. Kaufman.  Type 1 diabetes mellitus. , 2003, Pediatrics in review.

[13]  U. Johansson,et al.  Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. , 2003, Biochemical and biophysical research communications.

[14]  D. Greiner,et al.  Induction of tolerance for islet transplantation for type 1 diabetes , 2003, Current diabetes reports.

[15]  R. Gomis,et al.  Evidence of expression of endotoxin receptors CD14, toll‐like receptors TLR4 and TLR2 and associated molecule MD‐2 and of sensitivity to endotoxin (LPS) in islet beta cells , 2003, Clinical and experimental immunology.

[16]  W. Lowe,et al.  Clinical islet transplantation , 2003, Current diabetes reports.

[17]  M. Trucco,et al.  Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospects. , 2003, BioTechniques.

[18]  R. Bottino,et al.  Gene- and cell-based therapeutics for type I diabetes mellitus , 2003, Gene Therapy.

[19]  G. Soltész,et al.  Diabetes in the young: a paediatric and epidemiological perspective , 2003, Diabetologia.

[20]  P. Robbins,et al.  Protection of Islets by in SituPeptide-mediated Transduction of the IκB Kinase Inhibitor Nemo-binding Domain Peptide* , 2003, The Journal of Biological Chemistry.

[21]  K. Ekdahl,et al.  Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation , 2002, The Lancet.

[22]  F. Pattou,et al.  1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. , 2002, Endocrinology.

[23]  J. Contreras,et al.  17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. , 2002, Transplantation.

[24]  J. Contreras,et al.  Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets , 2002, Transplantation.

[25]  G. Nolan,et al.  Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors1 , 2002, Transplantation.

[26]  R. Bottino,et al.  Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. , 2002, Diabetes.

[27]  Meng Chen,et al.  Suppression of Autoimmune Diabetes by Viral IL-10 Gene Transfer1 , 2002, The Journal of Immunology.

[28]  J. Nadler,et al.  Lisofylline, a Novel Antiinflammatory Agent, Protects Pancreatic β-Cells from Proinflammatory Cytokine Damage by Promoting Mitochondrial Metabolism. , 2002, Endocrinology.

[29]  K. Ekdahl,et al.  Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. , 2002, Diabetes.

[30]  F. Bach,et al.  Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. , 2002, Diabetes.

[31]  S. Dowdy,et al.  Protein transduction technology. , 2002, Current opinion in biotechnology.

[32]  Y. Mullen,et al.  Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin. , 2002, Transplantation.

[33]  T. Mandrup-Poulsen,et al.  A choice of death – the signal-transduction of immune-mediated beta-cell apoptosis , 2001, Diabetologia.

[34]  D. Eizirik,et al.  Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. , 2001, Diabetes.

[35]  F. Bach,et al.  Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. , 2001, Diabetes.

[36]  G. Korbutt,et al.  SERINE-PROTEASE INHIBITION DURING ISLET ISOLATION INCREASES ISLET YIELD FROM HUMAN PANCREASES WITH PROLONGED ISCHEMIA1 , 2001, Transplantation.

[37]  D. Eizirik,et al.  Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP. , 2001, Diabetes.

[38]  C. Ricordi,et al.  Factors influencing Islet of Langerhans graft function and monitoring. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[39]  J. Contreras,et al.  Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement. , 2001, Surgery.

[40]  C. Ricordi,et al.  Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. , 2001, Diabetes.

[41]  M. Atkinson,et al.  Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors. , 2001, Diabetes.

[42]  F. Levine,et al.  Gene therapy for diabetes. , 2001, Frontiers in bioscience : a journal and virtual library.

[43]  C. Ricordi,et al.  ENDOTOXIN-MEDIATED DELAYED ISLET GRAFT FUNCTION IS ASSOCIATED WITH INCREASED INTRA-ISLET CYTOKINE PRODUCTION AND ISLET CELL APOPTOSIS1 , 2001, Transplantation.

[44]  J. Mai,et al.  Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[45]  F. Brunicardi,et al.  The Circulating Hormonal Milieu of the Endocrine Pancreas in Healthy Individuals, Organ Donors, and the Isolated Perfused Human Pancreas , 2000, Pancreas.

[46]  L. Rosenberg,et al.  Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. , 1999, The Journal of endocrinology.

[47]  R. Robertson,et al.  Prostaglandin E2 Mediates Inhibition of Insulin Secretion by Interleukin-1β* , 1999, The Journal of Biological Chemistry.

[48]  G. Elgue,et al.  Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? , 1999, Diabetes.

[49]  P. Robbins,et al.  Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. , 1999, Diabetes.

[50]  M. Mcdaniel,et al.  Tumor Necrosis Factor α-induced Pancreatic β-Cell Insulin Resistance Is Mediated by Nitric Oxide and Prevented by 15-Deoxy-Δ12,14-prostaglandin J2 and Aminoguanidine , 1999, The Journal of Biological Chemistry.

[51]  G. Korbutt,et al.  Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. , 1999, Diabetes.

[52]  T. Nakamura,et al.  Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts. , 1999, Transplantation.

[53]  T. Kafri,et al.  Gene transfer to human pancreatic endocrine cells using viral vectors. , 1999, Diabetes.

[54]  R. Alemany,et al.  Comparison of viral gene-deleted adenoviral vectors with the E1-deleted adenoviral vector in islets. , 1999, Transplantation proceedings.

[55]  M. Brendel,et al.  Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector , 1998, Diabetologia.

[56]  T. Albertson,et al.  Nonviral transfection of isolated islets of Langerhans. , 1998, Transplantation proceedings.

[57]  J. Mabley,et al.  Insulin‐like growth factor I reverses interleukin‐1β inhibition of insulin secretion, induction of nitric oxide synthase and cytokine‐mediated apoptosis in rat islets of Langerhans , 1997 .

[58]  C. Ricordi,et al.  Improved Human Islet Isolation Using a New Enzyme Blend, Liberase , 1997, Diabetes.

[59]  M. Hardy,et al.  Factors that can affect cadaveric islet graft function include hemodynamic changes in the donor prior to organ harvest. , 1996, Transplantation proceedings.

[60]  T. Starzl,et al.  Long-term culture of viable human pancreatic islets in pyruvate-rich medium. , 1995, Transplantation proceedings.

[61]  N. Welsh,et al.  Interleukin-1β Induced Activation of NF-κB in Insulin-Producing RINm5F Cells Is Prevented by the Protease Inhibitor Nα-p-Tosyl-L-Lysine Chloromethylketone , 1994 .

[62]  J. Santiago.  Lessons From the Diabetes Control and Complications Trial , 1993, Diabetes.

[63]  Y. Kuroda,et al.  A new, simple method for cold storage of the pancreas using perfluorochemical. , 1988, Transplantation.

[64]  Camillo Ricordi,et al.  Automated Method for Isolation of Human Pancreatic Islets , 1988, Diabetes.

[65]  P. Lacy,et al.  Transplantation of intact pancreatic islets in rats. , 1972, Surgery.

[66]  P. Allavena,et al.  Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. , 2002, Diabetes.

[67]  S. Lenzen,et al.  Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. , 1996, Free radical biology & medicine.

[68]  N. Welsh,et al.  Nicotinamide decreases nitric oxide production and partially protects human pancreatic islets against the suppressive effects of combinations of cytokines. , 1994, Autoimmunity.